Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06732245 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
A Phase 2 study, sponsored by Biomed Industries.
- Not yet
- Registry status
- Phase 2
- Development phase
- 224
- Enrollment target
NCT06732245: Clinical Trial Phase 2 study, sponsored by Biomed Industries.
NCT06732245 is a Phase 2 study that has not yet begun recruiting, run by Biomed Industries. The registered enrollment target is 224 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06732245, a Phase 2 study, has not yet begun recruiting, sponsored by Biomed Industries.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 224 participants
- Enrollment target
Study Summary
A phase 2 study to assess the efficacy of NA-931 alone or in addition to Tirzepatide to assess efficacy and safety in overweight or obese men and women
Primary Outcome
Change in total body weight will be measured from baseline to 48 weeks
Interventions
- DRUG Tirzepatide
- DRUG NA-931
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2026-08-15 |
| Est. Completion | 2027-12-15 |
| Phase | Phase 2 |
What is known before NCT06732245 opens enrollment
NCT06732245 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% higher).
The record links to 0 conditions, and to 2 interventions - of which Tirzepatide is the first listed.
NCT06732245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06732245 about?
NCT06732245 is a clinical study titled "Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese". A phase 2 study to assess the efficacy of NA-931 alone or in addition to Tirzepatide to assess efficacy and safety in overweight or obese men and women
What is the current status of trial NCT06732245?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 224 participants. The study started on 2026-08-15. Estimated completion is 2027-12-15.
What interventions are being tested in trial NCT06732245?
The interventions under investigation include: Tirzepatide (DRUG), NA-931 (DRUG).
Who is sponsoring clinical trial NCT06732245?
This trial is sponsored by Biomed Industries, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06732245's enrollment target sits among peer trials
224 269th of 2000 higher than 1,727 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI